Related Experiment Video
Updated: Dec 27, 2025

Models of Bone Metastasis
Published on: September 4, 2012
Potentiating bisphosphonate-based coordination complexes to treat osteolytic metastases
Gabriel Quiñones Vélez1, Lesly Carmona-Sarabia1, Waldemar A Rodríguez-Silva2
1Department of Chemistry, University of Puerto Rico, Río Piedras, San Juan, Puerto Rico 00931, USA. vilmali.lopez@upr.edu and Crystallization Design Institute, Molecular Sciences Research Center, University of Puerto Rico, San Juan, Puerto Rico 00926, USA.
Researchers developed novel bisphosphonate-based coordination complexes (BPCCs) using alendronate (ALEN) and bioactive metals. These new nano-sized BPCCs show enhanced cytotoxicity, offering improved drug delivery for bone disease treatment.
Area of Science:
- Materials Science
- Medicinal Chemistry
- Nanotechnology
Background:
- Alendronate (ALEN) is a clinically used bisphosphonate for bone diseases.
- Current formulations may have limitations in drug delivery and efficacy.
- Bisphosphonate-based coordination complexes (BPCCs) offer a novel approach to drug formulation.
Purpose of the Study:
- To synthesize and characterize novel bisphosphonate-based coordination complexes (BPCCs) using alendronate (ALEN) and bioactive metals (Ca2+, Zn2+, Mg2+).
- To investigate the structural, solid-state, dissolution, and cytotoxicity properties of these BPCCs.
- To explore nano-formulation strategies for enhanced drug delivery and therapeutic efficacy.
Main Methods:
- Hydrothermal synthesis of BPCCs with varying metal-to-alendronate ratios, temperatures, and pH.
- Single crystal X-ray diffraction for structural elucidation of five crystal forms.
- Dissolution studies in simulated gastric fluid and PBS, and cytotoxicity assays against MDA-MB-231 cells.
Main Results:
- Five distinct BPCC crystal structures were determined (ALEN-Ca forms I and II, ALEN-Zn forms I and II, ALEN-Mg).
- BPCCs exhibited pH-dependent degradation, with nano-emulsion synthesis yielding particle sizes down to 438 nm.
- Nano-sized ALEN-Ca BPCCs (nano-Ca@ALEN) demonstrated significantly higher cytotoxicity than bulk ALEN and ALEN-Ca crystals.
Conclusions:
- Novel BPCCs with tunable properties were successfully synthesized and characterized.
- Nano-sized BPCCs show promise for improved alendronate delivery and enhanced therapeutic effects.
- These findings support the development of advanced nano-formulations for treating bone-related diseases.
Related Concept Videos
Metal-Ligand Bonds
In these complexes, transition metals form coordinate covalent bonds, a kind of Lewis acid-base interaction in which both of the electrons in the bond are contributed by a donor (Lewis base) to an electron acceptor (Lewis acid). The Lewis acid in...
Complexometric Titration: Ligands
Essential Minerals for Bone Health
Calcium and Phosphorus
Calcium is a critical component of bones, especially in the form of calcium phosphate and calcium carbonate. Since the body cannot make calcium, it must be obtained from the diet. However, calcium cannot be absorbed from the small intestine without...
Osteoclasts in Bone Remodeling
EDTA: Auxiliary Complexing Reagents
Stereoisomerism
Isomers are different chemical species that have the same chemical formula.
Transition metal complexes often exist as geometric isomers, in which the same atoms are connected through the same types of bonds but with differences in their orientation in space. Coordination complexes with two different ligands in the cis and trans positions from a ligand of interest form isomers. For example, the octahedral [Co(NH3)4Cl2]+ ion has two isomers (Figure 1) In the cis...

